Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Rank	Δ	Cancer	Trial Gap Index (percentile points)	Percentile	Confidence	Sources	Why #n?
1	=	Malignant Colon Neoplasm	+55.6	100	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 22456 formula percentile(mortality_count) − percentile(active_trials) activity 225 burdenPercentile 92.6 activityPercentile 37 ranking row 2595898
2	=	Malignant Vulvar Neoplasm	+22.2	96.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 862 formula percentile(mortality_count) − percentile(active_trials) activity 54 burdenPercentile 29.6 activityPercentile 7.4 ranking row 2595899
3	=	Cutaneous Melanoma	+18.5	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 2964 formula percentile(mortality_count) − percentile(active_trials) activity 78 burdenPercentile 40.7 activityPercentile 22.2 ranking row 2595900
4	=	Malignant Vaginal Neoplasm	+14.8	88.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 396 formula percentile(mortality_count) − percentile(active_trials) activity 31 burdenPercentile 14.8 activityPercentile 0 ranking row 2595901
5	=	Malignant Ovarian Neoplasm	+14.8	85.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 14857 formula percentile(mortality_count) − percentile(active_trials) activity 684 burdenPercentile 85.2 activityPercentile 70.4 ranking row 2595902
6	=	Malignant Bladder Neoplasm	+11.2	81.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4062 formula percentile(mortality_count) − percentile(active_trials) activity 346 burdenPercentile 55.6 activityPercentile 44.4 ranking row 2595903
7	=	Malignant Laryngeal Neoplasm	+11.1	77.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 830 formula percentile(mortality_count) − percentile(active_trials) activity 66 burdenPercentile 25.9 activityPercentile 14.8 ranking row 2595904
8	=	Malignant Pancreatic Neoplasm	+7.4	74.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 16895 formula percentile(mortality_count) − percentile(active_trials) activity 904 burdenPercentile 88.9 activityPercentile 81.5 ranking row 2595905
9	=	Malignant Kidney Neoplasm	+3.7	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4680 formula percentile(mortality_count) − percentile(active_trials) activity 453 burdenPercentile 59.3 activityPercentile 55.6 ranking row 2595906
9	=	Malignant Thyroid Gland Neoplasm	+3.7	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 904 formula percentile(mortality_count) − percentile(active_trials) activity 176 burdenPercentile 33.3 activityPercentile 29.6 ranking row 2595907
11	=	Malignant Breast Neoplasm	0	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 40820 formula percentile(mortality_count) − percentile(active_trials) activity 2627 burdenPercentile 96.3 activityPercentile 96.3 ranking row 2595908
11	=	Malignant Lung Neoplasm	0	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 69356 formula percentile(mortality_count) − percentile(active_trials) activity 2644 burdenPercentile 100 activityPercentile 100 ranking row 2595909
11	=	Malignant Rectal Neoplasm	0	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3939 formula percentile(mortality_count) − percentile(active_trials) activity 386 burdenPercentile 48.1 activityPercentile 48.1 ranking row 2595910
14	=	Malignant Salivary Gland Neoplasm	-3.7	51.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 241 formula percentile(mortality_count) − percentile(active_trials) activity 63 burdenPercentile 7.4 activityPercentile 11.1 ranking row 2595911
15	=	Malignant Hypopharyngeal Neoplasm	-3.7	48.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 63 formula percentile(mortality_count) − percentile(active_trials) activity 53 burdenPercentile 0 activityPercentile 3.7 ranking row 2595912
16	=	Malignant Gastric Neoplasm	-3.7	44.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4692 formula percentile(mortality_count) − percentile(active_trials) activity 652 burdenPercentile 63 activityPercentile 66.7 ranking row 2595913
17	=	Malignant Central Nervous System Neoplasm	-7.4	40.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5688 formula percentile(mortality_count) − percentile(active_trials) activity 823 burdenPercentile 70.4 activityPercentile 77.8 ranking row 2595914
17	=	Multiple Myeloma	-7.4	40.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5063 formula percentile(mortality_count) − percentile(active_trials) activity 814 burdenPercentile 66.7 activityPercentile 74.1 ranking row 2595915
19	=	Malignant Cervical Neoplasm	-7.4	33.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3976 formula percentile(mortality_count) − percentile(active_trials) activity 505 burdenPercentile 51.9 activityPercentile 59.3 ranking row 2595917
19	=	Malignant Mesothelioma	-7.4	33.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 479 formula percentile(mortality_count) − percentile(active_trials) activity 96 burdenPercentile 18.5 activityPercentile 25.9 ranking row 2595916
21	=	Malignant Anal Neoplasm	-7.4	25.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 387 formula percentile(mortality_count) − percentile(active_trials) activity 68 burdenPercentile 11.1 activityPercentile 18.5 ranking row 2595918
22	=	Malignant Uterine Corpus Neoplasm	-7.5	22.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3449 formula percentile(mortality_count) − percentile(active_trials) activity 411 burdenPercentile 44.4 activityPercentile 51.9 ranking row 2595919
23	=	Non-Hodgkin Lymphoma	-11.1	18.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9661 formula percentile(mortality_count) − percentile(active_trials) activity 2168 burdenPercentile 81.5 activityPercentile 92.6 ranking row 2595920
24	=	Hodgkin Lymphoma	-11.1	14.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 557 formula percentile(mortality_count) − percentile(active_trials) activity 179 burdenPercentile 22.2 activityPercentile 33.3 ranking row 2595921
25	=	Leukemia	-11.1	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9590 formula percentile(mortality_count) − percentile(active_trials) activity 1769 burdenPercentile 77.8 activityPercentile 88.9 ranking row 2595922
25	=	Malignant Liver Neoplasm	-11.1	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5766 formula percentile(mortality_count) − percentile(active_trials) activity 906 burdenPercentile 74.1 activityPercentile 85.2 ranking row 2595923
27	=	Malignant Esophageal Neoplasm	-26	3.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 2963 formula percentile(mortality_count) − percentile(active_trials) activity 518 burdenPercentile 37 activityPercentile 63 ranking row 2595924
28	=	Malignant Nasopharyngeal Neoplasm	-37	0	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 210 formula percentile(mortality_count) − percentile(active_trials) activity 261 burdenPercentile 3.7 activityPercentile 40.7 ranking row 2595925

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash c723410cee4a36d5d659c0f9

Methodology

How this table was built

Formula: percentile(mortality_count) − percentile(active_trials)
Version: ci-trial-gap-v1
Scope: USA · Female · all ages · 2006 · top-level cancers
Scope key: geo=USA|sex=female|age=all|year=2006|level=top
Eligible entities: 28
Generated: Sep 29, 2026, 06:30 AM UTC
Inputs hash: c723410cee4a36d5d659c0f9
Sources: U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality clinicaltrials cdc-wonder seer iarc-globocan
Aggregation: none

Eligibility

requires: mortality_count
active_trials
entityLevel: top

Full methodology · ties share a rank (1, 2, 2, 4) · previous rank refers to the last snapshot of the same scope.

Download CSV (with attribution)

Burden and lethality metrics depend on registry definitions (site groups, standard population, estimate type). Compare only within one table.